IL SCIENCE CO., LTD. |
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
| 3,130 KRW | +4.33% |
|
+13.20% | -9.14% |
Valuation
| Fiscal Period: December | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|
| Capitalization 1 | 37,636 | 64,196 | 1,48,077 | 66,183 | 88,956 |
| Enterprise Value (EV) 1 | 40,311 | 78,841 | 1,67,765 | 95,677 | 1,23,210 |
| P/E ratio | -10.8 x | -13.6 x | -16.5 x | -35.2 x | -4.64 x |
| Yield | - | - | - | - | - |
| Capitalization / Revenue | 1.86 x | 3.66 x | 3.04 x | 1.35 x | 2.28 x |
| EV / Revenue | 1.99 x | 4.49 x | 3.45 x | 1.95 x | 3.15 x |
| EV / EBITDA | 32.2 x | -17.2 x | 49 x | 75 x | -8.79 x |
| EV / FCF | - | -1,32,86,877 x | -1,50,49,873 x | -76,21,701 x | -5,22,14,400 x |
| FCF Yield | - | -0% | -0% | -0% | -0% |
| Price to Book | 3.09 x | 7.22 x | 18.5 x | 4.22 x | 15.6 x |
| Nbr of stocks (in thousands) | 19,602 | 21,222 | 22,436 | 23,553 | 25,822 |
| Reference price 2 | 1,920 | 3,025 | 6,600 | 2,810 | 3,445 |
| Announcement Date | 19/03/21 | 19/03/21 | 21/03/22 | 21/03/23 | 20/03/24 |
1KRW in Million2KRW
Estimates
Income Statement Evolution (Annual data)
| Fiscal Period: December | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|
| Net sales 1 | 20,281 | 17,553 | 48,635 | 49,165 | 39,078 |
| EBITDA 1 | 1,252 | -4,582 | 3,423 | 1,276 | -14,017 |
| EBIT 1 | 917.6 | -5,113 | 2,529 | -721.1 | -17,113 |
| Operating Margin | 4.52% | -29.13% | 5.2% | -1.47% | -43.79% |
| Earnings before Tax (EBT) 1 | -2,707 | -4,935 | -7,422 | 1,366 | -18,619 |
| Net income 1 | -2,726 | -4,566 | -8,529 | 1,938 | -18,557 |
| Net margin | -13.44% | -26.01% | -17.54% | 3.94% | -47.49% |
| EPS 2 | -177.4 | -223.0 | -399.2 | -79.74 | -742.1 |
| Free Cash Flow | - | -5,934 | -11,147 | -12,553 | -2,360 |
| FCF margin | - | -33.81% | -22.92% | -25.53% | -6.04% |
| FCF Conversion (EBITDA) | - | - | - | - | - |
| FCF Conversion (Net income) | - | - | - | - | - |
| Dividend per Share | - | - | - | - | - |
| Announcement Date | 19/03/21 | 19/03/21 | 21/03/22 | 21/03/23 | 20/03/24 |
1KRW in Million2KRW
Estimates
Balance Sheet Analysis
| Fiscal Period: December | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|
| Net Debt 1 | 2,675 | 14,645 | 19,688 | 29,494 | 34,254 |
| Net Cash position 1 | - | - | - | - | - |
| Leverage (Debt/EBITDA) | 2.137 x | -3.196 x | 5.753 x | 23.12 x | -2.444 x |
| Free Cash Flow | - | -5,934 | -11,147 | -12,553 | -2,360 |
| ROE (net income / shareholders' equity) | - | -44.6% | -61.4% | 10.8% | -95.9% |
| ROA (Net income/ Total Assets) | - | -9.49% | 2.8% | -0.62% | -14.1% |
| Assets 1 | - | 48,133 | -3,04,943 | -3,13,199 | 1,32,014 |
| Book Value Per Share 2 | 621.0 | 419.0 | 356.0 | 666.0 | 221.0 |
| Cash Flow per Share 2 | 350.0 | 113.0 | 314.0 | 45.90 | 311.0 |
| Capex 1 | 5,286 | 6,798 | 7,689 | 6,281 | 5,034 |
| Capex / Sales | 26.06% | 38.73% | 15.81% | 12.77% | 12.88% |
| Announcement Date | 19/03/21 | 19/03/21 | 21/03/22 | 21/03/23 | 20/03/24 |
1KRW in Million2KRW
Estimates
EPS & Dividend
Year-on-year evolution of the PER
Change in Enterprise Value/EBITDA
Annual profits - Rate of surprise
| 1st Jan change | Capi. | |
|---|---|---|
| -9.14% | 5.86Cr | |
| +28.19% | 798.31Cr | |
| -10.22% | 370.56Cr | |
| +14.67% | 205.56Cr | |
| +12.12% | 120.36Cr | |
| -1.79% | 57Cr | |
| -44.49% | 49Cr | |
| +12.13% | 39Cr | |
| -28.04% | 39Cr | |
| -32.15% | 36Cr |
- Stock Market
- Equities
- A307180 Stock
- Financials IL Science Co., Ltd.